SCHEMBL4683424

SCHEMBL4683424

COc1cc(C=CCBr)cc(OCC(=O)O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 6/20 0.58
▸ PPARA Q07869 6/20 0.58
▸ PPARD Q03181 5/20 0.58
▸ FFAR1 O14842 3/20 0.58
▸ LMNA P02545 1/20 0.51
▸ CYP1A1 P04798 3/20 0.44
▸ CYP1B1 Q16678 3/20 0.44
▸ BACE1 P56817 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ ESR1 P03372 4/20 0.40
▸ AHR P35869 2/20 0.40
▸ ABL1 P00519 3/20 0.40
▸ BCR P11274 3/20 0.40
▸ TTR P02766 2/20 0.40
▸ ABCB1 P08183 2/20 0.40
▸ ALOX5 P09917 2/20 0.40
▸ NQO2 P16083 2/20 0.40
▸ PTGS2 P35354 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4683420 1.00 PPARG (0.58) PPARGPPARAPPARDFFAR1LMNA
SCHEMBL14501365 0.89 PPARG (0.46) PPARGPPARAPPARDFFAR1CYP1A1
SCHEMBL4685042 0.87 PPARG (0.60) PPARGPPARAPPARDFFAR1LMNA
SCHEMBL4685048 0.87 PPARG (0.60) PPARGPPARAPPARDFFAR1LMNA
SCHEMBL5124637 0.81 LMNA (0.72) PPARGPPARAPPARDFFAR1LMNA
SCHEMBL5387842 0.81 LMNA (0.72) PPARGPPARAPPARDFFAR1LMNA
SCHEMBL3362007 0.79 PPARG (0.81) PPARGPPARAPPARDFFAR1LMNA
SCHEMBL3362005 0.79 PPARG (0.81) PPARGPPARAPPARDFFAR1LMNA
SCHEMBL4683421 0.78 LMNA (0.53) PPARGPPARALMNAALOX5PTGS2
SCHEMBL4683425 0.78 LMNA (0.53) PPARGPPARALMNAALOX5PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1386913-B1 PYRROLE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO (JP) 2008-07-16 — — EP disclosed
US-7220773-B2 Heterocylic amines used as antidiabetic or hyperglycemic agents DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-05-22 — — US disclosed
US-20040162331-A1 Pyrrole derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2004-08-19 — — US disclosed
EP-1386913-A1 PYRROLE DERIVATIVE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-02-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162331-A1 Pyrrole derivative SLC5A1, GLP1R, SLC5A2 PPARG 126/4885PPARA 31/4885PPARD 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback